• Return to Headlines

Watch for Continued Losses in Shares of Nevro Corp (NVRO)

By David Diaz

Nevro Corp (NYSE:NVRO) traded at a new 52-week low today of $60.57. Approximately 1 million shares have changed hands today, as compared to an average 30-day volume of 577,000 shares.

Nevro Corporation is a medical device company focused on providing products for patients suffering from debilitating chronic pain. The Company develops and commercializes a spinal cord stimulation system for the treatment of chronic pain.

Potential upside of 55.3% exists for Nevro Corp, based on a current level of $61.16 and analysts' average consensus price target of $95.00. Nevro Corp shares should first meet resistance at the 50-day moving average (MA) of $78.33 and find additional resistance at the 200-day MA of $81.02.

In the past 52 weeks, shares of Nevro Corp have traded between the current low of $60.57 and a high of $94.34 and are now at $61.16. Over the last five market days, the 200-day moving average (MA) has gone down 0.5% while the 50-day MA has declined 2.1%.

SmarTrend is monitoring the recent change of momentum in Nevro Corp. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Nevro Corp in search of a potential trend change.

Keywords: 52 week high/lows nevro corp

Ticker(s): NVRO